ASIP, agouti signaling protein, 434

N. diseases: 89; N. variants: 26
Disease: Adult Acute Lymphocytic Leukemia ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia 		0.040 Biomarker disease BEFREE Native vs. PEG-ASP administered according to availability in each center were prospectively evaluated in adults with high-risk ALL. 29165013 2018
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia 		0.040 AlteredExpression disease BEFREE ASP and ATIII activity was measured in 76 children with ALL treated according to the ALL IC BFM 2002 protocol. 28060110 2017
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia 		0.040 Biomarker disease BEFREE Asparaginase (ASP) is a cornerstone in the treatment of acute lymphoblastic leukemia (ALL). 28440015 2017
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
Adult Acute Lymphocytic Leukemia 		0.040 GeneticVariation disease BEFREE Thrombotic events (TEs) are serious secondary complications in children with acute lymphoblastic leukemia (ALL) who receive L-asparaginase (ASP) therapy; however, the prevalence of TEs has not been established. 12518376 2003